Treatment approaches for managing patients with hematological malignancies in thetime of COVID-19 pandemic

Authors

GÜLDANE CENGİZ SEVAL
PERVİN TOPÇUOĞLU
TANER DEMİRER

DOI

10.3906/sag-2101-276

Abstract

Background/aim: The COVID-19 pandemic is a unique challenge to the care of patients with hematological malignancies. We aim to provide supportive guidance to clinicians making individual patients decisions during the COVID-19 pandemic, in particular during periods that access to healthcare resources may be limited. Conclusion: This review also provides recommendations, which are convenient in evaluating indications for therapy, reducing therapy-associated immunosuppression, and reducing healthcare utilization in patients with specific hematological malignancies in the COVID-19 era. Specific decisions regarding treatment of hematological malignancies will need to be individualized, based on disease risk, risk of immunosuppression, rates of community transmission of SARS-CoV-2, and available local healthcare resources.

Keywords

COVID-19, SARS-CoV-2, hematological malignancies

First Page

2799

Last Page

2809

Recommended Citation

SEVAL, GÜLDANE CENGİZ; TOPÇUOĞLU, PERVİN; and DEMİRER, TANER (2021) "Treatment approaches for managing patients with hematological malignancies in thetime of COVID-19 pandemic," Turkish Journal of Medical Sciences: Vol. 51: No. 6, Article 1. https://doi.org/10.3906/sag-2101-276
Available at: https://journals.tubitak.gov.tr/medical/vol51/iss6/1